SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000882104-16-000216
Filing Date
2016-11-15
Accepted
2016-11-15 17:26:34
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B5 pdli-20161115424b5doc.htm 424B5 663908
2 PROSPECTUS S-3 a20160606s3docfor424b5.htm EX-1.1 197260
3 formula1a01.jpg GRAPHIC 10846
4 formula2.jpg GRAPHIC 12279
5 formula3.jpg GRAPHIC 12007
6 formula4.jpg GRAPHIC 12519
7 formula5.jpg GRAPHIC 11555
8 formula6.jpg GRAPHIC 13739
9 pdl-logoa10.jpg GRAPHIC 59351
10 pdlilogoa02.jpg GRAPHIC 7005
  Complete submission text file 0000882104-16-000216.txt   1022383
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-211970 | Film No.: 162000693
SIC: 2836 Biological Products, (No Diagnostic Substances)